Disease | cystic fibrosis |
Symptom | C0151317|chronic infection |
Sentences | 17 |
PubMedID- 24527289 | Sequence analysis of clinical isolates obtained from seven cystic fibrosis (cf) patients with chronic infections that were collected over 16.3 years identified loss-of-function mutants for 7 of these 15 genes. |
PubMedID- 22970300 | Possession of certain genes and expression of their gene products may predispose different strains of h. influenzae to successful chronic infection in patients with cystic fibrosis or copd. |
PubMedID- 24136845 | Pseudomonas aeruginosa frequently establishes chronic infections in the airways of patients suffering from cystic fibrosis (cf). |
PubMedID- 24532839 | The identification of novel protein targets could contribute to the development of much needed antimicrobial therapies to treat the chronic infections found in patients with cystic fibrosis. |
PubMedID- 21264306 | Pseudomonas aeruginosa, a ubiquitous bacteria found in diverse ecological niches, is an important cause of acute infections in immunocompromised individuals and chronic infections in patients with cystic fibrosis. |
PubMedID- 23363478 | Pseudomonas aeruginosa is an opportunistic human pathogen and a common cause of chronic infections in individuals with cystic fibrosis (cf). |
PubMedID- 24704788 | In fact, biofilm communities exhibit increased tolerance towards conventional anti-microbial treatments and sterilization techniques and are responsible for many chronic infections associated with cystic fibrosis and endocarditis6,7 as well as nosocomial infections8. |
PubMedID- 25666799 | Alginate is one of the three major pseudomonas exopolysaccharides, and it is only produced by mucoid strains that establish chronic infections in patients with cystic fibrosis (cf). |
PubMedID- 20729192 | The type vi secretion system (t6ss) contributes to the virulence of burkholderia cenocepacia, an opportunistic pathogen causing serious chronic infections in patients with cystic fibrosis. |
PubMedID- 20300602 | During long-term chronic infections of cystic fibrosis patients, pseudomonas aeruginosa adapts to the lung environment, generating various different morphotypes including small colony variants (scvs), small, strongly adherent colonies whose appearance correlates with persistence of infection. |
PubMedID- 22919658 | Burkholderia cepacia complex (bcc) bacteria can cause devastating chronic infections in people with cystic fibrosis. |
PubMedID- 24370741 | A new study uses whole-genome and population sequencing approaches to identify evidence of adaptive evolution in burkholderia dolosa genomes isolated from chronic infections in patients with cystic fibrosis. |
PubMedID- 20097812 | The ubiquitous opportunistic human pathogen pseudomonas aeruginosa secretes a viscous extracellular polysaccharide, called alginate, as a virulence factor during chronic infection of patients with cystic fibrosis. |
PubMedID- 22555873 | Pseudomonas aeruginosa is an opportunistic pathogen that causes chronic infections in the lungs of individuals with cystic fibrosis. |
PubMedID- 21091830 | Pseudomonas aeruginosa can cause acute lung infections in intubated patients or chronic infections in patients with cystic fibrosis (cf). |
PubMedID- 25742660 | Mycobacterium abscessus specific t-cells were detected in the blood of cystic fibrosis patients with confirmed chronic infection and a subgroup of patients without evidence of mycobacterium abscessus infection. |
PubMedID- 24260482 | Burkholderia cepacia complex (bcc) is an opportunistic bacterial pathogen that causes chronic infections in people with cystic fibrosis (cf). |
Page: 1